OGT enhances customer experience with new Cytocell website
Oxford, UK – 7 March 2018. Oxford Gene Technology (OGT), The Molecular Genetics Company, has launched a new version of its Cytocell® fluorescence in situ hybridisation (FISH) probes website - designed to provide a wealth of information and advice, offer refined functionality, and be easy-to-use. Cytocell is well known for its complete and comprehensive range of FISH probes, exceptional customer support, service and expertise. In the spirit of sharing this expertise and knowledge, OGT has redeveloped the website to increase accessibility to the brand’s know-how.
Taking on board feedback from customers requesting a visual search aid, OGT has created an interactive chromosome search tool designed to be familiar to cytogeneticists and facilitate the quick and easy identification of appropriate probes. The tool provides a visual representation of the chromosome using the ISCN (International System for Human Cytogenetic Nomenclature) G-banding end users are familiar with, and uniquely, enables scrolling over the chromosome bands to pinpoint the location to be targeted by a probe. The new website also includes a redesigned probe search function, allowing users to quickly locate probes by conducting a free text search or by filtering using a comprehensive set of probe filter options. New product pages make it easy to access an increased number of resources and simpler to request samples and quotes.
A re-vamped support section includes Cytocell’s popular FISH ‘n’ Tips area, a collection of tips from Cytocell experts—soon to be opened up for contributions from end users—enabling the sharing of knowledge and best practice within the FISH community. The site now also features instructional video content including a detailed protocol video for pre-treatment of formalin fixed, paraffin embedded samples prior to FISH - a notoriously difficult step in the process. In addition, the quick-to-access FAQ section has expanded and features question grouping by stage of the FISH process to make relevant information easy to locate.
Emma Shipstone, EVP Marketing at OGT commented, “Our Cytocell brand is already very well known for the excellent level of knowledge and support we provide customers. We wanted to expand the global reach of this to enable customers even easier access - providing them with expertise and information online, and at their fingertips, 24/7. The new website is all about providing more of our support in a quick, easy and accessible fashion. We’ve listened to what our customers have been telling us and the feedback we’re getting from the new site has been enormously positive.”
For more information please visit www.cytocell.com.
For further information, please contact: Emma Shipstone EVP Marketing
Oxford Gene Technology, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, Oxfordshire, OX5 1PF, U.K.
Notes for editors:
About Oxford Gene Technology
Oxford Gene Technology (OGT) provides world-class genetics research solutions to leading clinical and academic research institutions. Founded by Professor Sir Edwin Southern, and with customers in over 60 countries worldwide, OGT has a strong reputation and increasing share in the large and growing genomic medicine market. The Company’s Cytocell®, CytoSure™ and SureSeq™ range of fluorescence in situ hybridisation (FISH), microarray and next generation sequencing (NGS) products deliver high-quality genetic analysis, enabling accurate identification and confirmation of the causative variation underlying genetic disease.
CytoSure™ and SureSeq™: For Research Use Only; Not for Use in Diagnostic Procedures. Cytocell®: Some products may not be available in your region
About Sysmex Corporation
Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 40 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. The company is also exploring emerging opportunities in the life science field. Its R&D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for cell, gene and protein analysis. The company, headquartered in Kobe, Japan, has subsidiaries in North America, Latin America, Europe, the Middle East, Africa, China and Asia Pacific and employs about 8,000 employees worldwide. Sysmex Corporation is listed in the top tier of the Tokyo Stock Exchange.
For more information about Sysmex Corporation and its affiliate companies, please visit http://www.sysmex.co.jp/en/.